To facilitate the development of treatments for cancer, and for other purposes.
Analysis under review: This bill has generated analysis that may be too generic or incomplete. Clause-level evidence remains available below.
Summary
What This Bill Does
This bill, To facilitate the development of treatments for cancer, and for other purposes., changes federal law or congressional policy affecting health care providers and patients. The main policy domain is Healthcare, Education, Environment.
Who Benefits and How
health care providers and patients may benefit from new authority, funding, eligibility, regulatory clarity, or reduced risk created by the bill.
Who Bears the Burden and How
federal implementing agencies, health care providers and patients may take on implementation duties, reporting obligations, compliance costs, or oversight responsibilities.
Key Provisions
- Section H774816609E8C4B05B950A38331E4C2D4: 1. Short title This Act may be cited as the Finn Sawyer Access to Cancer Testing Act.
- Section H2B2E700D95DB4629A24FB719AF758CA9: 2. Coverage of cancer diagnostic and laboratory tests Section 1861 of the Social Security Act (42 U.S.C. 1395x) is amended— in subsection (s)(2)— in...
- Section H417A6C6CCC3E4742915DDC22767F17EA: 3. Education and awareness program on genomic testing The Secretary of Health and Human Services, in coordination with the Director of the National Human...
Evidence Chain:
This summary is generated from the full bill text using AI analysis. Expand "Detailed Analysis" below for identified beneficiaries/burden bearers with clause-level evidence links.
At a Glance
What This Bill Does
This bill, To facilitate the development of treatments for cancer, and for other purposes., changes federal law or congressional policy affecting health care providers and patients.
Key Policy Areas
Healthcare, Education, Environment
Primary Purpose
This bill, To facilitate the development of treatments for cancer, and for other purposes., changes federal law or congressional policy affecting health care providers and patients.
Policy Domains
Whole bill
Identified Gains
- health care providers and patients
Identified Costs
- federal implementing agencies
- health care providers and patients
Sponsors
Legislative Progress
IntroducedMs. Matsui (for herself, Mr. Bilirakis, Mr. Thompson of California, …
Impact analysis is available but no clear stakeholder effects identified. View clause-level analysis →
Bill Structure & Actor Mappings
Who is "The Secretary" in each section?
- "secretary_of_health_and_human_services"
- → Secretary of Health and Human Services
We use a combination of our own taxonomy and classification in addition to large language models to assess meaning and potential beneficiaries. High confidence means strong textual evidence. Always verify with the original bill text.
Learn more about our methodology